Skip to main content
. 2025 Sep 15;17(9):7170–7179. doi: 10.62347/QQLV5111

Table 5.

Comparison of adverse reactions [n (%)]

Groups Control group (n=42) Observation group (n=48) χ2 P
Dizziness and fatigue 1 (2.38) 2 (4.17)
Nausea and vomiting 1 (2.38) 2 (4.17)
Arrhythmia 1 (2.38) 1 (2.08)
Chest tightness 0 (0.00) 1 (2.08)
Rash 1 (2.38) 1 (2.08)
Total occurrence 4 (9.52) 7 (14.58) 0.534 0.465